Invention Grant
- Patent Title: Thiazolidin 4-one derivatives
- Patent Title (中): 噻唑烷-4-酮衍生物
-
Application No.: US12496945Application Date: 2009-07-02
-
Publication No.: US08273779B2Publication Date: 2012-09-25
- Inventor: Christoph Binkert , Martin Bolli , Boris Mathys , Claus Mueller , Michael Scherz , Oliver Nayler
- Applicant: Christoph Binkert , Martin Bolli , Boris Mathys , Claus Mueller , Michael Scherz , Oliver Nayler
- Applicant Address: CH Allschwil
- Assignee: Actelion Pharmaceuticals Ltd.
- Current Assignee: Actelion Pharmaceuticals Ltd.
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Assoiates LLC
- Priority: WOPCT/EP03/13072 20031121
- Main IPC: A61K31/41
- IPC: A61K31/41 ; A01N43/82 ; C07D277/00 ; C07D327/04 ; C07D343/00
Abstract:
The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
Public/Granted literature
- US20090275625A1 NOVEL THIAZOLIDIN 4-ONE DERIVATIVES Public/Granted day:2009-11-05
Information query
